Vera M. Artiko

Visegradska 26 St, 11000
Belgrade, SE, Serbia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 58 publications

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) Monitoring of Rapidly Progressive Low-Risk Cutaneous Melanoma: A Case Report of Durable Response to Combined Stereotactic Body Radiotherapy (SBRT) and Immunotherapy.

Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (FDG PET/CT) Monitoring of Rapidly Progressive Low-Risk Cutaneous Melanoma: A Case Report of Durable Response to Combined Stereotactic Body Radiotherapy (SBRT) and Immunotherapy.

Journal: Cureus

Published: June 14, 2026

18F-FDG PET/CT-based recurrence patterns and survival outcomes in esophageal carcinoma: a single center experience.

18F-FDG PET/CT-based recurrence patterns and survival outcomes in esophageal carcinoma: a single center experience.

Journal: Radiology and oncology

Published: June 07, 2026

Role of [123I]I-mIBG cardiac scintigraphy in the differential diagnosis of Parkinson's disease - our experience.

Role of [123I]I-mIBG cardiac scintigraphy in the differential diagnosis of Parkinson's disease - our experience.

Journal: Nuclear medicine review. Central & Eastern Europe

Published: March 23, 2026

Correlation between semiquantitative and quantitative [18F]FDG PET/CT parameters and serum tumor marker levels in recurrent esophageal carcinoma: up to 12-year follow-up study.

Correlation between semiquantitative and quantitative [18F]FDG PET/CT parameters and serum tumor marker levels in recurrent esophageal carcinoma: up to 12-year follow-up study.

Journal: Nuclear medicine review. Central & Eastern Europe

Published: March 03, 2026

Cutaneous melanoma histopathologic features and laboratory findings as predictors of sentinel lymph node status and progression-free survival: a single-center experience.

Cutaneous melanoma histopathologic features and laboratory findings as predictors of sentinel lymph node status and progression-free survival: a single-center experience.

Journal: Acta dermatovenerologica Alpina, Pannonica, et Adriatica

Published: February 19, 2026

Multiple machine learning models for the prediction of an early response to radioactive iodine therapy in hyperthyroidism: ablative dose concept.

Multiple machine learning models for the prediction of an early response to radioactive iodine therapy in hyperthyroidism: ablative dose concept.

Journal: Thyroid research

Published: November 02, 2025

The Role of Nuclear Medicine in Prostate Cancer.

The Role of Nuclear Medicine in Prostate Cancer.

Journal: Diagnostics (Basel, Switzerland)

Published: October 09, 2025

The Complementary Roles of 18F-Fluorocholine and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in an Evaluation of A Patient With Parathyroid Carcinoma: A Case Report.

The Complementary Roles of 18F-Fluorocholine and 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography in an Evaluation of A Patient With Parathyroid Carcinoma: A Case Report.

Journal: Molecular imaging and radionuclide therapy

Published: September 05, 2025

Predictors of a response to radioactive iodine therapy in hyperthyroidism - ablative dose concept: A 23-year single center 914-patient experience.

Predictors of a response to radioactive iodine therapy in hyperthyroidism - ablative dose concept: A 23-year single center 914-patient experience.

Journal: Revista espanola de medicina nuclear e imagen molecular

Published: August 10, 2025

Viability Test in Prediction of Response to Cardiac Resynchronization Therapy.

Viability Test in Prediction of Response to Cardiac Resynchronization Therapy.

Journal: Journal of clinical medicine

Published: June 24, 2025

Clinical characteristics and survival of patients with calcitonin-secreting neuroendocrine neoplasms: experience from a series of 71 patients.

Clinical characteristics and survival of patients with calcitonin-secreting neuroendocrine neoplasms: experience from a series of 71 patients.

Journal: Endocrine

Published: May 24, 2025

18F-FDG parameters as therapy response predictors in patients with diffuse large B-cell lymphoma: A single centre experience.

18F-FDG parameters as therapy response predictors in patients with diffuse large B-cell lymphoma: A single centre experience.

Journal: Hellenic journal of nuclear medicine

Published: January 13, 2025

Showing 1-12 of 58

Last Updated: 09/26/2026